USE OF BIOGENIC PEPTIDES IN COMPLEX TREATMENT OF INFLAMMATORY DISEASES OF PARODONT IN PATIENTS WITH DIABETES MELLITUS II TYPE. JournalNX 2021, 7 (04), 168-169.